A Double-Blind, Randomized, Cross-Over Design, Phase 1 Pharmacodynamic Study to Investigate the Effect of Different Formulations of AZD3355 for the Development of Paresthesiae After Dosing in Healthy Subjects.

Trial Profile

A Double-Blind, Randomized, Cross-Over Design, Phase 1 Pharmacodynamic Study to Investigate the Effect of Different Formulations of AZD3355 for the Development of Paresthesiae After Dosing in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2010

At a glance

  • Drugs Lesogaberan (Primary)
  • Indications Gastro-oesophageal reflux
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 02 Dec 2010 Actual end date changed from Jul 2008 to Jun 2008 as reported by ClinicalTrials.gov.
    • 11 Aug 2008 Status changed from active, no longer recruiting to completed.
    • 24 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top